Abstract: Embodiments of the technology described herein are based upon the discoveries that neutrophil extracellular traps (NETs) provide a stimulus for thrombus formation and that NETs are present in stored blood products. Accordingly, some embodiments relate to methods of treating and preventing toxicity of NETs and thrombosis caused by NETs. Additional embodiments are directed towards methods of treating stored blood products to prevent transfusion-related injuries.

Abstract: Embodiments of the technology described herein are based upon the discoveries that neutrophil extracellular traps (NETs) provide a stimulus for thrombus formation and that NETs are present in stored blood products. Accordingly, some embodiments relate to methods of treating and preventing toxicity of NETs and thrombosis caused by NETs. Additional embodiments are directed towards methods of treating stored blood products to prevent transfusion-related injuries.

Abstract: Embodiments include apparatuses, methods, and systems for computer assisted or autonomous driving. An apparatus may include a storage and a safety operation controller disposed in a computer assisted or autonomous driving vehicle. The storage may store a safety operation configuration and a list of safety operations to be performed on one or more device components. The safety operation configuration and the list of safety operations may be provided by a first party. The safety operation configuration may be used to configure selected ones of the list of safety operations by a second party different from the first party to obtain configured safety operations to be performed on the one or more device components. The safety operation controller may perform the configured safety operations on the one or more device components. Other embodiments may also be described and claimed.

Abstract: Embodiments of the technology described herein are based upon the discoveries that neutrophil extracellular traps (NETs) provide a stimulus for thrombus formation and that NETs are present in stored blood products. Accordingly, some embodiments relate to methods of treating and preventing toxicity of NETs and thrombosis caused by NETs. Additional embodiments are directed towards methods of treating stored blood products to prevent transfusion-related injuries.

Abstract: Embodiments of the technology described herein are based upon the discoveries that neutrophil extracellular traps (NETs) provide a stimulus for thrombus formation and that NETs are present in stored blood products. Accordingly, some embodiments relate to methods of treating and preventing toxicity of NETs and thrombosis caused by NETs. Additional embodiments are directed towards methods of treating stored blood products to prevent transfusion-related injuries.

Abstract: Embodiments of the technology described herein are based upon the discoveries that neturophil extracellular traps (NETs) provide a stimulus for thrombus formation and that NETs are present in stored blood products. Accordingly, some embodiments are directed towards methods of treating stored blood products to prevent transfusion-related injuries e.g., preventing transfusion-related acute lung injury (TRALI), by treating blood transfusion products with an anti-Neutrophil Extracellular Trap (NET) compound.

Abstract: Technologies for controlling timing calibration of a dedicated inter-integrated circuit data bus by a primary microcontroller are disclosed. The primary microcontroller performs a data transfer with a secondary integrated circuit using the dedicated inter-integrated circuit data bus, and determines a duration of the data transfer. If the duration is outside of an acceptable range, the primary microcontroller updates one or more data transfer timing parameters so that the duration of future data transfers are closer to the acceptable range.

Abstract: Embodiments include apparatuses, methods, and systems for computer assisted or autonomous driving. An apparatus may include a storage and a safety operation controller disposed in a computer assisted or autonomous driving vehicle. The storage may store a safety operation configuration and a list of safety operations to be performed on one or more device components. The safety operation configuration and the list of safety operations may be provided by a first party. The safety operation configuration may be used to configure selected ones of the list of safety operations by a second party different from the first party to obtain configured safety operations to be performed on the one or more device components. The safety operation controller may perform the configured safety operations on the one or more device components. Other embodiments may also be described and claimed.

Abstract: Embodiments of the technology described herein are based upon the discoveries that neutrophil extracellular traps (NETs) provide a stimulus for thrombus formation and that NETs are present in stored blood products. Accordingly, some embodiments relate to methods of treating and preventing toxicity of NETs and thrombosis caused by NETs. Additional embodiments are directed towards methods of treating stored blood products to prevent transfusion-related injuries.

Abstract: Technologies for controlling timing calibration of a dedicated inter-integrated circuit data bus by a primary microcontroller are disclosed. The primary microcontroller performs a data transfer with a secondary integrated circuit using the dedicated inter-integrated circuit data bus, and determines a duration of the data transfer. If the duration is outside of an acceptable range, the primary microcontroller updates one or more data transfer timing parameters so that the duration of future data transfers are closer to the acceptable range.

Abstract: Embodiments of the technology described herein are based upon the discoveries that neturophil extracellular traps (NETs) provide a stimulus for thrombus formation and that NETs are present in stored blood products. Accordingly, some embodiments relate to methods of treating and preventing toxicity of NETs and thrombosis caused by NETs. Additional embodiments are directed towards methods of treating stored blood products to prevent transfusion-related injuries.

Abstract: Embodiments of the technology described herein are based upon the discoveries that neturophil extracellular traps (NETs) provide a stimulus for thrombus formation and that NETs are present in stored blood products. Accordingly, some embodiments relate to methods of treating and preventing toxicity of NETs and thrombosis caused by NETs. Additional embodiments are directed towards methods of treating stored blood products to prevent transfusion-related injuries.